Reach Out 2: Emergency Department-Initiated Hypertension Mobile Health Intervention Connecting Multiple Health Systems
Launched by NORTHWESTERN UNIVERSITY · Apr 25, 2024
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The Reach Out 2 clinical trial is looking at how a mobile health program can help people with high blood pressure who visit the emergency department (ED). Many people may not know they have high blood pressure, and this trial aims to see if using a mobile app can lower their blood pressure more effectively than standard care. If successful, the program could potentially reduce the risk of serious health problems like heart attacks, strokes, and dementia for many individuals if it is used in emergency departments across the country.
To be eligible for the trial, participants need to be adults aged 18 and older who visit the ED and have high blood pressure readings. Specifically, they should have a systolic blood pressure of 160 or higher or a diastolic reading of 100 or higher. Participants will need to have a cell phone that can receive text messages and be likely to go home after their ED visit. The trial is currently recruiting participants, and those who join can expect to receive guidance and support through the mobile health program to help manage their blood pressure effectively.
Gender
ALL
Eligibility criteria
- While in the ED, the patient must meet all of the following:
- • Adult (≥18 y/o)
- • At least one BP with Systolic BP ≥160 or a Diastolic BP ≥100 (criteria 1)
- • If the patient has repeated measurements after achieving Criteria 1, at least one of the repeat BP remains systolic BP ≥140 or a diastolic BP ≥90
- • Must have cell phones with text-messaging capability
- • Likely to be discharged from the ED
- Exclusion Criteria for Main Trial Participants:
- • Critical illness
- • Unable to read English (\<1% at study site)
- • Incarcerated
- • Pregnant
- • Pre-existing condition making 6-month follow-up unlikely
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Flint, Michigan, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported